What Has Been The Evolution of the Human Immunodeficiency Virus (HIV) Diagnosis Market in Recent Years?
The human immunodeficiency virus (hiv) diagnosis market has seen considerable growth due to a variety of factors.
• The human immunodeficiency virus (HIV) diagnosis market has experienced strong growth in recent years. It will grow from $4.2 billion in 2024 to $4.68 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.4%.
Growth is attributed to the expansion of voluntary counseling and testing programs, the development of HIV antibody tests, the HIV/AIDS epidemic, and community-led initiatives.
How Will the Human Immunodeficiency Virus (HIV) Diagnosis Market?
The human immunodeficiency virus (hiv) diagnosis market is expected to maintain its strong growth trajectory in upcoming years.
• The human immunodeficiency virus (HIV) diagnosis market is projected to grow to $7.12 billion by 2029, at a CAGR of 11.0%.
The growth is driven by public health campaigns, equity and inclusivity efforts, routine testing, community-led initiatives, and the expansion of self-testing. Trends include advancements in testing technologies, targeted testing strategies, community-based testing, and policy and funding priorities.
Which Factors Are Boosting Growth In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
The increase in blood donations is expected to fuel the growth of the HIV diagnosis market. More blood donations provide a larger pool of samples for HIV testing, improving diagnostic accuracy. NHS Blood and Transplant reported an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024, supporting growth in the HIV diagnosis sector.
What Key Areas Define The Segmentation Of The Global Human Immunodeficiency Virus (HIV) Diagnosis Market?
The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented –
1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing
Pre-Book The Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Leading firms in the HIV diagnosis market are focusing on the creation of chip-based real-time PCR test solutions for HIV in an effort to boost precision, lessen the response time, and broaden reach. These chip-based real-time PCR test solutions for HIV serve as diagnostic instruments that employ microfluidic chips or compact integrated circuits to execute real-time polymerase chain reaction (PCR) tests to detect HIV. As an illustration, Molbio Diagnostics, a molecular diagnostics producer based in India, introduced the Truenat HIV-1 test, a chip-based real-time PCR test, for the comprehensive detection and identification of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma, in August 2022. This exam aims to support the assessment of the HIV-1 viral load in patients suffering from HIV-1 infection. Based on Taqman chemistry, the test displays high primer sensitivity and distinctness and necessitates a slight sample volume of 6 mcL. Furthermore, it incorporates an insightful chip comprising lot-specific data to quantify results and has a chip re-use lock and a reaction port with a design resistant to contamination and evaporation.
Who Are the Key Players In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are:
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Siemens Healthineers
• Roche Diagnostics
• Becton Dickinson and Company
• Hologic Inc.
• bioMérieux SA
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Bio-Techne Corporation
• Alere Inc.
• Cepheid Inc.
• OraSure Technologies Inc.
• Advanced Instruments Inc.
• BBI Solutions
• Chembio Diagnostic Systems Inc.
• BioLytical Laboratories Inc.
• Avioq Inc.
• Advanced Biochemicals Ltd.
• Advanced Molecular Diagnostics
• Atila BioSystems Inc.
• BioAssay Works LLC
• Chemtron Biotech Inc.
What Is The Most Dominant Region In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
